Delivery Order SPE2DB22D3004-SPE2DB24FPY04
- Not listed
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,794.36, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm-fixed-price basis. The contract is a delivery order that does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $2,472.16 and a completion date of March 6, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) that...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The contract, valued at $5,233.55, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,075.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that has been awarded numerous contracts by the DLA and other federal agencies. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025,...
- This federal contract award is for the delivery of 4,566,077,688 units of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm fixed price delivery order. The contractor, Amerisourcebergen Drug Corp, is a major pharmaceutical distributor and has been awarded this $3,301.26 contract with a completion date of October 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that has extensive experience supplying medical products to the U.S. government. The contract is a Delivery Order valued at $1,499.45, with a firm fixed price pricing type. It has an ultimate completion date of June 5, 2024. Amerisourcebergen...
- This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA), a major defense agency under the U.S. Department of Defense (DoD). The contract, valued at $2,059.51, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a Firm Fixed Price basis. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies to the Defense Logistics Agency (DLA) Troop Support Medical program. The contract was awarded to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a ceiling value of $2,691.54 and a period of performance through March 28, 2024. Amerisourcebergen Drug Corp. holds...
- The federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S to the Defense Logistics Agency (DLA). The $2,081.46 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that provides medical products to federal government agencies, particularly military and veterans' healthcare programs. The contract has an ultimate completion date of March 27, 2025 and is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a ceiling value of $2,784.60 and runs through March 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026. This IDC serves as a primary...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPY04Delivery Order
This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $2,305.43 and a period of performance through April 10, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award is a task order issued under that IDC. The contract does not have any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/9/24 |